Mark Jaros
Society of Paediatric Oncology and Haematology(DE)Ludwig-Maximilians-Universität München(DE)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Restless Legs Syndrome Research, Botulinum Toxin and Related Neurological Disorders, Lipoproteins and Cardiovascular Health, Sleep and Wakefulness Research
Most-Cited Works
- → Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol(2020)1,475 cited
- → Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia(2020)774 cited
- → NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial(2018)406 cited
- → NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis(2019)252 cited
- → Pooled Patient-Level Analysis of Inclisiran Trials in Patients With Familial Hypercholesterolemia or Atherosclerosis(2021)223 cited
- → Inclisiran and cardiovascular events: a patient-level analysis of phase III trials(2022)199 cited